샘플 요청 목록

 카트 문의
시장보고서
상품코드
1514037

세계의 맞춤 의약품 시장

Personalized Medicines
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 216 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

맞춤 의약품 시장은 2030년까지 8,223억 달러에 이를 것으로 예상됩니다.

2023년에 5,978억 달러로 평가된 맞춤 의약품 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 4.7%로 성장하여, 2030년에는 8,223억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 개인화된 영양 및 웰니스는 복합 연간 성장률(CAGR) 4.5%로 성장을 지속하고, 분석 기간이 끝날 때 4,840억 달러에 도달할 것으로 예측됩니다. 맞춤형 의료 분야의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 5.0%로 추정됩니다.

미국 시장은 추정 1,588억 달러를 나타낼 것으로 예측되며 중국은 복합 연간 성장률(CAGR) 4.4%로 성장할 것으로 예측됩니다.

미국의 맞춤 의약품 시장은 2023년 1,588억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 1,303억 달러 규모에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR) 4.4%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR) 각각 4.2%와 3.9%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 3.5%로 성장할 것으로 예측됩니다.

세계 맞춤 의약품 시장 - 주요 동향과 촉진요인 요약

개인화된 의료(PM)는 전통적인 획일적 접근에서 개인의 유전적, 에피유전체적, 임상적 프로파일을 기반으로 한 보다 개인화된 전략으로 이동하는 건강 관리의 변화적인 변화를 의미합니다. 이 방법은 유전체과 에피유전체의 상세한 데이터를 이용하여 의료를 정확하게 개별화함으로써 치료의 유효성을 높이고, 부작용을 경감하며, 의료비 전체를 억제하는 것입니다. 전통적인 방법과는 달리, 개인화된 의료는 각 개인의 독특한 유전자 구성에 맞게 치료를 조정하고, 치료 결과를 개선하며, 부작용의 위험을 줄입니다. 이 접근법은 치료뿐만 아니라 예방에도 확산되며, 유전자 마커 및 기타 바이오 마커를 활용하여 질병의 위험 요소를 조기에 확인하고 질병의 발병을 예방할 수 있습니다.

CRISPR-Cas9 유전자 편집과 단클론항체의 개발과 같은 분자의학의 기술적 진보는 질병 메커니즘을 정확하게 표적으로 하는 특이성이 높은 치료를 가능하게 함으로써, 맞춤형 의료에 혁명을 가져오고 있습니다. 이 특이성은 건강한 세포에 대한 부수적 손상을 최소화하고 치료 효과를 높입니다. 게다가 인공지능(AI)과 머신러닝은 유전체 시퀀싱로부터 생성된 방대한 데이터 세트를 분석함으로써 맞춤형 의료에서 점점 더 중요한 역할을 하게 되었습니다. 이러한 기술은 패턴을 파악하고 새로운 치료 대상의 발견을 가속화함으로써 치료의 맞춤화와 효과를 향상시키는 데 도움이 됩니다. 개인화된 의료의 능동적인 특성은 진단 및 치료 계획의 정확성을 향상시킬 뿐만 아니라 보다 효과적인 질병 예방 전략을 가능하게 하고 장기적으로 비용 효율성을 높일 수 있습니다.

그 잠재력에도 불구하고, 개인화된 의료는 여러 과제에 직면하고 있습니다. 유전 검사에 드는 고가의 비용과 고급 맞춤형 의료 기술을 주류 건강 관리 진료에 통합하는 것은 큰 장벽입니다. 게다가, 윤리적 고려와 환자의 프라이버시 보호에 대한 필요성은 의료 목적으로 유전자 데이터의 사용에 대한 신뢰를 유지하는데 있어 가장 중요합니다. 개인화된 의료 분야는 질병의 유전적 기반에 대한 이해가 깊어지고, 개인의 요구에 맞는 보다 효과적인 치료에 대한 수요가 증가하고, 헬스케어 시스템에 있어서 상당한 비용 절감의 기회에도 영향을 받고 있습니다. 또한 규제 당국의 지원과 AI 및 머신러닝의 진보는 맞춤형 의료의 예측력을 강화하여 임상 의사 결정에 필수적인 도구가 되고 있습니다. 맞춤형 의료가 진화를 계속하는 동안, 개별 환자의 유전자 프로파일에 맞는보다 정확하고 예측 가능하고 효과적인 치료를 제공함으로써 의료 실천을 재정의하여 전반적인 의료 질과 환자의 결과를 향상시킬 것입니다.

조사 대상 기업 예(전 87건)

  • Abbott Molecular
  • Beckman Coulter, Inc.
  • bioMerieux SA
  • Bristol-Myers Squibb Company
  • Dako Denmark A/S
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Hologic, Inc.
  • Lab 21 Limited
  • Macrogen, Inc.
  • NeoGenomics Laboratories, Inc.
  • Novartis AG
  • QIAGEN NV
  • Rosetta Genomics Ltd.
  • Thermo Fischer Scientific Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계 기타 지역

제4장 경쟁

BJH 24.07.25

Global Personalized Medicines Market to Reach US$822.3 Billion by 2030

The global market for Personalized Medicines estimated at US$597.8 Billion in the year 2023, is expected to reach US$822.3 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Personalized Nutrition & Wellness, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$484.0 Billion by the end of the analysis period. Growth in the Personalized Medical Care segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$158.8 Billion While China is Forecast to Grow at 4.4% CAGR

The Personalized Medicines market in the U.S. is estimated at US$158.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$130.3 Billion by the year 2030 trailing a CAGR of 4.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Personalized Medicines Market - Key Trends and Drivers Summarized

Personalized medicine (PM) represents a transformative shift in healthcare, moving away from the traditional one-size-fits-all approach to a more tailored strategy based on individual genetic, epigenomic, and clinical profiles. This method enhances the efficacy of treatments, reduces side effects, and curtails overall healthcare costs by using detailed genomic and epigenomic data to personalize medical treatments precisely. Unlike conventional methods, personalized medicine adjusts treatments to the unique genetic composition of each individual, improving outcomes and reducing the risk of adverse reactions. This approach extends beyond treatment to prevention, utilizing genetic markers and other biomarkers to identify disease risk factors early, potentially preventing disease onset.

The technological advancements in molecular medicine, such as CRISPR-Cas9 gene editing and the development of monoclonal antibodies, are revolutionizing personalized medicine by enabling highly specific therapies that target disease mechanisms precisely. This specificity minimizes collateral damage to healthy cells and enhances treatment efficacy. Furthermore, artificial intelligence (AI) and machine learning are playing an increasingly critical role in personalized medicine by analyzing the vast datasets generated from genomic sequencing. These technologies help identify patterns and speed up the discovery of new therapeutic targets, thereby improving the customization and effectiveness of medical treatments. The proactive nature of personalized medicine not only improves the accuracy of diagnoses and treatment plans but also allows for more effective disease prevention strategies, which can be more cost-effective over time.

Despite its immense potential, personalized medicine faces several challenges that must be addressed to realize its full potential. The high costs of genetic testing and the integration of sophisticated personalized medicine technologies into mainstream healthcare practice are significant barriers. Additionally, ethical considerations and the need to protect patient privacy are paramount to maintaining trust in the use of genetic data for medical purposes. The field of personalized medicine is also influenced by an increased understanding of the genetic bases of diseases, growing demand for more effective treatments tailored to individual needs, and significant cost savings opportunities for healthcare systems. Moreover, regulatory support and the advancement of AI and machine learning are enhancing the predictive power of personalized medicine, making it an indispensable tool in clinical decision-making. As personalized medicine continues to evolve, it is set to redefine healthcare practices by providing more precise, predictive, and effective medical treatments tailored to the genetic profiles of individual patients, thereby enhancing the overall quality of care and patient outcomes.

Select Competitors (Total 87 Featured) -

  • Abbott Molecular
  • Beckman Coulter, Inc.
  • bioMerieux SA
  • Bristol-Myers Squibb Company
  • Dako Denmark A/S
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Hologic, Inc.
  • Lab 21 Limited
  • Macrogen, Inc.
  • NeoGenomics Laboratories, Inc.
  • Novartis AG
  • QIAGEN NV
  • Rosetta Genomics Ltd.
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Recent Market Activity
    • Market Outlook
    • Adoption of Personalized Medicines - A Peek into Developed and Developing Economies
    • Increasing Market Availability of Personalized Medicines
    • Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area
    • Constraints in Traditional Approach to Treatment Creates Need and Demand for Personalized Medicine
    • Economics of Personalized Medicine
    • Is Emergence of Personalized Medicine Signaling the End of Blockbusters?
    • Personalized Medicines - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rapid Advances in Genomic Sequencing Technology Propel Personalized Medicine
    • Increased Investment in Biotechnology Spurs Growth in Tailored Treatments
    • Data Integration from Real-World Sources Strengthens Precision Medicine
    • Consumer Demand for Personalized Healthcare Accelerates Market Expansion
    • AI and Machine Learning Enhance Predictive Capabilities in Medicine Personalization
    • Rising Prevalence of Chronic Diseases Drives Demand for Customized Medication
    • Wearable Health Technology Integration Supports Personalized Health Monitoring
    • Pharmacogenomics Gains Traction in Drug Development and Dosage Optimization
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Personalized Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Personalized Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Personalized Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Personalized Nutrition & Wellness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Personalized Nutrition & Wellness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Personalized Nutrition & Wellness by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Personalized Medical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Personalized Medical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Personalized Medical Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Personalized Medicine Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Personalized Medicine Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Personalized Medicine Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Personalized Medicine Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Personalized Medicine Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Personalized Medicine Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Personalized Medicines Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2014, 2024 & 2030
  • JAPAN
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2014, 2024 & 2030
  • CHINA
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2014, 2024 & 2030
  • EUROPE
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Personalized Medicines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Personalized Medicines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Personalized Medicines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2014, 2024 & 2030
  • FRANCE
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2014, 2024 & 2030
  • GERMANY
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 53: Rest of World Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of World Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of World 16-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제